REFERENCES

1. Ambre J, Ruo TI, Nelson J, Belknap S. Urinary excretion of cocaine, benzoylecgonine, and ecgonine

methyl ester in humans. Journal of Anal Toxicol. 1988;12:301-306.

2. Chan A, Isbister GK, Kirkpatrick CM, Dufful SB.

pointes: evaluation of a QT nomogram. QJM. 2007;100:609-615.

3. Blake KV, Massey KL, Hendeles L, Nickerson D, Neims A. Relative efficacy of phenytoin and

phenobarbital for the prevention of theophylline-induced seizures in mice. Ann Emerg Med. 1988;17:1024-1028.

4. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose. 662 cases with evaluation

of oral acetylcysteine treatment. Arch Intern Med. 1981;141:380-385.

5. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant

hepatic failure. Gastroenterology. 1989;97:439-445.

6. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of

acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). NEngl J Med. 1988;319:1557-1562.

7. Johnson MT, McCammon CA, Mullins ME, Halcomb SE. Evaluation of a simplified N-acetylcysteine

dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother. 2011;45:713-720.

8. Vertrees JE, McWilliams BC, Kelly HW. Repeated oral administration of activated charcoal for

treating aspirin overdose in young children. Pediatrics. 1990;85:594-598.

9. Goldfrank L, Weisman RS, Errick JK, Lo MW A dosing nomogram for continuous infusion intravenous

naloxone. Ann Emerg Med. 1986;15:566-570.

10. Mixter CG IIIrd, Moran JM, Austen WG. Cardiac and peripheral vascular effects of

diphenylhydantoin sodium. Am J Cardiol. 1966;17:332-338.

11. O'Brien TJ, Cascino GD, So EL, Hanna DR. Incidence and clinical consequence of the purple glove

syndrome in patients receiving intravenous phenytoin.

12. Ghannoum M, Laliberte M, Nolin TD, et al. Extracorporeal treatment for valproic acid poisoning:

systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015;53:454-465.

13. Hojer J, Malmlund HO, Berg A. Clinical features in 28 consecutive cases of laboratory confirmed

massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol. 1993;31:449-458.

14. Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone,

carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol. 1980;17:51-57.

15. Boyer EW, Shannon M. The serotonin syndrome. NEngl J Med. 2005;352:1112-1120.

16. Boehnert MT, Lovejoy FH, Jr. Value of the QRS duration versus the serum drug level in predicting

seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. NEngl J Med. 1985;313:474-479.

17. Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and

arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 1995;26:195-201.

18. Linden CH, Rumack BH, Strehlke C. Monoamine oxidase inhibitor overdose. Ann Emerg Med.

1984;13:1137-1144.

19. Camus M, Hennere G, Baron G, et al. Comparison of lithium concentrations in red blood cells and

plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity. Eur J Clin Pharmacol. 2003;59:583-587.

20. Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal treatment for lithium poisoning: systematic

review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol. 2015;10:875- 887.

21. Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker

and calcium channel-blocker poisoning. Clin Toxicol (Phila). 2011;49:277-283.

22. Seger DL, Loden JK. Naloxone reversal of clonidine toxicity: dose, dose, dose. Clin Toxicol (Phila).

2018;56:873-879.

23.

prognostic significance and therapeutic implications. Clin Toxicol. 1973;6:153-162.

24. Chan BS, Isbister GK, O'Leary M, Chiew A, Buckley NA. Efficacy and effectiveness of anti-digoxin

antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Clin Toxicol (Phila). 2016;54:488-494.

25. Boldy DA, Vale JA, Prescott LF. Treatment of phenobarbitone poisoning with repeated oral

administration of activated charcoal. Q J Med. 1986;61:997-1002.

26. Fluyau D, Mitra P, Lorthe K. Antipsychotics for amphetamine psychosis. A systematic review. Front

Psychiatry. 2019;10:740.

27. McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial

infarction: a scientific statement from the American heart association acute cardiac care Committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897-1907.

28. Robertson KE, Martin TN, Rae AP. Brugada-pattern ECG and cardiac arrest in cocaine toxicity:

reading between the white lines. Heart. 2010;96:643-644.

29. Johnston JA, Lineberry CG, Ascher JA, et al. A 102-center prospective study of seizure in association

with bupropion. J Clin Psychiatry. 1991;52:450-456.

30. Caillier B, Pilote S, Castonguay A, et al. QRS widening and QT prolongation under bupropion: a

unique cardiac electrophysiological profile. Fundam Clin Pharmacol. 2012;26:599-608.

31. Yavarovich ER, Bintvihok M, McCarty JC, Breeze JL, LaCamera P. Association between

dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay. J Intensive Care. 2019;7:49.

32. Myrick H, Malcolm R, Randall PK, et al. A double-blind trial of gabapentin versus lorazepam in the

treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009;33:1582-1588.

33. Buckley NA, Juurlink DN, Isbister G, Bennett MH, Lavonas EJ. Hyperbaric oxygen for carbon

monoxide poisoning. Cochrane Database Syst Rev. 2011;2011:Cd002041.